Fred Telling
Known title: DirectorCIK: 0001382225
Fred Telling's purchase track record
How the stock did after each of Fred Telling's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since March 30, 2022
Stock higher 6 months later
0%
3 months: 33%
Median 6-month return
-36.1%
3 months: 0.0%
Beat the S&P 500
0%
median -20.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/17/2022 | OGEN | $3K | 0.0% | -46.9% | +4.8% |
| 5/18/2022 | OGEN | $62K | +46.2% | -19.2% | +0.9% |
| 3/30/2022 | OGEN | $66K | 0.0% | -36.1% | -19.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OGEN | ▼ Sell | Open Market | 210 | $198 | 12/12/2025 | View on chart |
| OGEN | ▼ Sell | Open Market | 3,597 | $1K | 12/6/2024 | View on chart |
| OGEN | ▼ Sell | Open Market | 3,500 | $12K | 11/30/2023 | View on chart |
| OGEN | ▲ Buy | Grant | 25,000 | $0 | 8/8/2023 | View on chart |
| OGEN | ▲ Buy | Open Market | 10,084 | $3K | 6/17/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 78,673 | $23K | 5/24/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 3,500 | $1K | 5/23/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 65,718 | $19K | 5/20/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 56,806 | $16K | 5/19/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 15,303 | $4K | 5/18/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 59,053 | $21K | 3/31/2022 | View on chart |
| OGEN | ▲ Buy | Open Market | 124,785 | $45K | 3/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.